CompuGroup Medical SE & Co. KGaA
CMPVF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $351 | $286 | $309 | $283 |
| % Growth | 22.8% | -7.3% | 8.9% | – |
| Cost of Goods Sold | $258 | $44 | $54 | $45 |
| Gross Profit | $83 | $242 | $254 | $238 |
| % Margin | 23.6% | 84.5% | 82.4% | 84% |
| R&D Expenses | $6 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $53 | $219 | $220 | $238 |
| Operating Expenses | $61 | $219 | $220 | $238 |
| Operating Income | $106 | $22 | $35 | $0 |
| % Margin | 30.3% | 7.8% | 11.2% | 0% |
| Other Income/Exp. Net | -$97 | -$7 | -$31 | $12 |
| Pre-Tax Income | $9 | $16 | $4 | $12 |
| Tax Expense | $3 | $5 | $10 | $4 |
| Net Income | $6 | $11 | -$6 | $9 |
| % Margin | 1.7% | 3.8% | -2.1% | 3% |
| EPS | 0.12 | 0.211 | -0.13 | 0.17 |
| % Growth | -43.1% | 262.3% | -176.5% | – |
| EPS Diluted | 0.12 | 0.211 | -0.13 | 0.17 |
| Weighted Avg Shares Out | 52 | 52 | 52 | 52 |
| Weighted Avg Shares Out Dil | 52 | 52 | 52 | 52 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $3 | $0 | $0 |
| Interest Expense | $9 | $9 | $3 | $14 |
| Depreciation & Amortization | $32 | $27 | $29 | $27 |
| EBITDA | $53 | $52 | $36 | $54 |
| % Margin | 15.2% | 18% | 11.6% | 19.1% |